Nos Publications

Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study
lédée et al, JRI 2016.pdf
Document Adobe Acrobat [445.7 KB]

 

The Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro Fertilization.

Lédée N, Petitbarat M, Chevrier L, Vitoux D, Vezmar K, Rahmati M, Dubanchet S, Gahéry H, Bensussan A, Chaouat G.

Am J Reprod Immunol. 2016 Jan 18. doi: 10.1111/aji.12483. [Epub ahead of print]

 

 

Préparer l'endomètre à l'implantation embryonnaire
Medecine de la Reproduction Préparer l'e[...]
Document Adobe Acrobat [1.6 MB]
Impediments to implantation
Nathalie_Ledee_Intl_Innovation_142_Resea[...]
Document Adobe Acrobat [2.3 MB]

 

New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side.

Lédée N, Petitbarat M, Rahmati M, Dubanchet S, Chaouat G, Sandra O, Perrier-d'Hauterive S, Munaut C, Foidart JM.J Reprod Immunol. 2011 Mar;88(2):118-23. doi: 10.1016/j.jri.2011.01.007. Epub 2011 Feb 18. Review.

 

TWEAK appears as a modulator of endometrial IL-18 related cytotoxic activity of uterine natural killers. Petitbarat M, Rahmati M, Sérazin V, Dubanchet S, Morvan C, Wainer R, de Mazancourt P, Chaouat G, Foidart JM, Munaut C, Lédée N. PLoS One. 2011 Jan 7;6(1):e14497. doi: 10.1371/journal.pone.0014497.

 

Tolerance to the foetal allograft? Chaouat G, Petitbarat M, Dubanchet S, Rahmati M, Ledée N.Am J Reprod Immunol. 2010 Jun;63(6):624-36. doi: 10.1111/j.1600-0897.2010.00832.x. Epub 2010 Mar 29. Review.

 

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor inducible-14 might regulate the effects of interleukin 18 and 15 in the human endometrium. Petitbarat M, Serazin V, Dubanchet S, Wayner R, de Mazancourt P, Chaouat G, Lédée N.Fertil Steril. 2010 Aug;94(3):1141-3. doi: 10.1016/j.fertnstert.2009.10.049. Epub 2009 Dec 11.

 

 

Uterine receptivity and cytokines: new concepts and new applications.Lédée N, Dubanchet S, Oger P, Meynant C, Lombroso R, Ville Y, Chaouat G.Gynecol Obstet Invest. 2007;64(3):138-43.

 

matricelab@gmail.com

 06 41 67 46 25

 

Version imprimable Version imprimable | Plan du site
© societé MatriceLAB Innove